|Oppenheimer & Co.||Hartaj Singh and Emma Nealon|
|ROTH Capital Partners||Jotin Marango, M.D., Ph.D.|
|Maxim Group||Jason McCarthy, Ph.D.|
|B. Riley FBR, Inc.||George Zavoico, Ph.D.|
|H.C. Wainwright||Andrew Fein|
Actinium Pharmaceuticals, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Actinium Pharmaceuticals, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Actinium Pharmaceuticals, Inc. or its management. Actinium Pharmaceuticals, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.